Austrian BioTech startup Epitome Therapeutics announces €4 million in funding to advance programmes and grow team

4 views0 likes0 comments

Originally published byEU-Startups

Vienna-based Epitome Therapeutics, a BioTech company advancing precision epigenome editing for programmable gene expression, today announced a total funding of €4 million to advance development programmes and grow the company’s team. The pre-seed round, comprising an oversubscribed €2 million pre-seed round and €2 million in non-dilutive grant funding, was co-led by XISTA Science Ventures and […]

The post Austrian BioTech startup Epitome Therapeutics announces €4 million in funding to advance programmes and grow team appeared first on EU-Startups.